Technical Information

Permissible Adjustment to LC Parameters under Isocratic Elution Conditions in International Harmonization of Pharmacopoeias

According to pharmacopoeias, many drugs are prescribed to be analyzed by high pressure liquid chromatography (HPLC) using conventional column dimensions and parameters. The United States Pharmacopeia (USP) and the International Harmonization of Pharmacopoeias allow for changes in LC parameters to the extent that they fulfill system suitability requirements for UHPLC.
The permissible adjustment to LC parameters under isocratic elution conditions in International Harmonization of Pharmacopoeias (Stage 4) is shown below.

Column

Stationary phase Unchangeable
Particle size (dp) L/dp is changeable in the range of −25% to +50%
Column length (L)

Mobile phase

pH ±0.2
Salt concentration of buffer solution ±10%
Solvent composition The minor solvent composition is changeable in the greater of ±30% (relative) or ±2% (absolute).

Other LC parameters

Flow rate F2 = F1 x [(dc22 x dp1)/(dc12 x dp2)]
 F1:original frow rate
 F2:modified flow rate
 dc1:original column inner diameter
 dc2:modified column inner diameter
 dp1:original particle size
 dp2:modified particle size
When the particle sizes are changed from ≥ 3 µm to < 3 µm, F2 is changeable within the range of ±50% if the column efficiency does not decrease by more than 20%.
Temperature ±10°C
Detector wavelength Unchangeable
Injection volume If the column dimension is changed, the injection volume is changeable according to the below equation.
Vinj2 = Vinj1 x [(L2 x dc22)/(L1 x dc12)]
 Vinj1:original injection volume
 Vinj2:modified injection volume
 L1:original column length
 L2:modified column length
 dc1:original column inner diameter
 dc2:modified column inner diameter
Even if the column dimension is not changed, the injection volume is changeable within the range fulfilling the system suitability requirements.

*Please refer to the original article written by the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH).